Find A Physician
More on Children's Hospital of NewYork-Presbyterian/Weill Cornell Appoints Two Division Chiefs
Hospital News
More on Children's Hospital of NewYork-Presbyterian/Weill Cornell Appoints Two Division Chiefs
Research and Clinical Trials
More on Children's Hospital of NewYork-Presbyterian/Weill Cornell Appoints Two Division Chiefs
Health Library
More on Children's Hospital of NewYork-Presbyterian/Weill Cornell Appoints Two Division Chiefs
Clinical Services
More on Children's Hospital of NewYork-Presbyterian/Weill Cornell Appoints Two Division Chiefs
Children's Hospital of NewYork-Presbyterian/Weill Cornell Appoints Two Division Chiefs
Children's Hospital of NewYork-Presbyterian/Weill Cornell Appoints Two Division Chiefs
New York, NY
(Oct 12, 2004)
Children's Hospital of NewYork-Presbyterian/Weill Cornell has appointed two new Division Chiefs. Dr. Barry E. Kosofsky, an authority in genetic and intrauterine factors that alter brain development, especially prenatal exposures to drugs or abuse, has been named Chief of the Division of Pediatric Neurology. And Dr. Mark E. Dovey, an expert in the treatment of pediatric cystic fibrosis, has been appointed Chief of the Division of Allergy, Immunology, and Pulmonary.
I am pleased to announce the appointment of two outstanding pediatriciansto the position of division chief, said Dr. Gerald M. Loughlin, Pediatrician-in-Chiefat Children's Hospital of NewYork-Presbyterian/Weill Cornell, and Chairman andNancy C. Paduano Professor of Pediatrics at Weill Cornell Medical College. Theyboth bring extensive knowledge and experience, offering the highest standardsin treatment. Their demonstrated leadership makes them ideal division chiefsin the Department of Pediatrics.
The former Chief of the Division of Pediatric Neurology, Dr. Abe Chutorian, is currently part-time Attending Neurologist at NewYork-Presbyterian/Weill Cornell. The Interim Chief of the Division of Allergy, Immunology, and Pulmonary, Dr. Mary Di Maio, is currently a voluntary faculty member at Weill Cornell Medical College.
Dr. Barry E. Kosofsky
Dr. Barry E. Kosofsky, who has also been named Professor of Pediatrics at Weill Cornell Medical College and Attending Pediatrician at NewYork-Presbyterian/Weill Cornell, joins the Hospital following 19 years at Harvard Medical School, where he was Associate Professor of Neurology. At Massachusetts General Hospital, he was Associate Neurologist and Director of the Child Neurology Residency Training Program. Dr. Kosofsky received a medical degree and Ph.D. from Johns Hopkins University; pediatric residency training from Children's Hospital, Boston; and fellowship training at Massachusetts General Hospital. He is board certified in Neurology with Special Competence in Child Neurology.
Dr. Kosofsky's research centers on the interaction of maternal, genetic, and postnatal influences on the development of the child brain. He has been particularly concerned with the impact of maternal substance abuse on fetal brain development and the implications on subsequent behavior. In his clinical practice, Dr. Kosofsky will continue his commitment to treat drug- and alcohol-exposed children.
Dr. Kosofsky currently serves as the Chair of the Scientific Selection Committee for the Child Neurology Society. He also founded and directed the Substances of Abuse Exposure Follow-up (SAEF) Clinic, which has recently expanded to include a clinical research component utilizing high-resolution structural brain imaging methods to better diagnose and treat diseases affecting the developing brain, including such prenatal toxic exposures.
Dr. Mark E. Dovey
Dr. Mark E. Dovey was appointed Assistant Professor of Pediatrics at Weill Cornell Medical College and Assistant Attending Pediatrician at NewYork-Presbyterian/Weill Cornell. He was previously Instructor in Pediatrics at Harvard Medical School and Assistant in Pulmonary Medicine at Children's Hospital, Boston. He received a medical degree from Duke University School of Medicine, pediatric residency training at Johns Hopkins Hospital, and pediatric pulmonary fellowship training at Boston Children's Hospital. He is board certified in both Pediatrics and Pediatric Pulmonology.
Dr. Dovey's research training and experience have focused on the clinical investigation of disease markers and novel therapeutic agents for cystic fibrosis lung disease.2453291pubjvb9001&&17:08-11- 4-2004kebloom10:30-10-13-200410_12c_04
Children's Hospital of NewYork-Presbyterian/Weill Cornell has appointed two new Division Chiefs. Dr. Barry E. Kosofsky, an authority in genetic and intrauterine factors that alter brain development, especially prenatal exposures to drugs or abuse, has been named Chief of the Division of Pediatric Neurology. And Dr. Mark E. Dovey, an expert in the treatment of pediatric cystic fibrosis, has been appointed Chief of the Division of Allergy, Immunology, and Pulmonary.
I am pleased to announce the appointment of two outstanding pediatriciansto the position of division chief, said Dr. Gerald M. Loughlin, Pediatrician-in-Chiefat Children's Hospital of NewYork-Presbyterian/Weill Cornell, and Chairman andNancy C. Paduano Professor of Pediatrics at Weill Cornell Medical College. Theyboth bring extensive knowledge and experience, offering the highest standardsin treatment. Their demonstrated leadership makes them ideal division chiefsin the Department of Pediatrics.
The former Chief of the Division of Pediatric Neurology, Dr. Abe Chutorian, is currently part-time Attending Neurologist at NewYork-Presbyterian/Weill Cornell. The Interim Chief of the Division of Allergy, Immunology, and Pulmonary, Dr. Mary Di Maio, is currently a voluntary faculty member at Weill Cornell Medical College.
Dr. Barry E. Kosofsky
Dr. Barry E. Kosofsky, who has also been named Professor of Pediatrics at Weill Cornell Medical College and Attending Pediatrician at NewYork-Presbyterian/Weill Cornell, joins the Hospital following 19 years at Harvard Medical School, where he was Associate Professor of Neurology. At Massachusetts General Hospital, he was Associate Neurologist and Director of the Child Neurology Residency Training Program. Dr. Kosofsky received a medical degree and Ph.D. from Johns Hopkins University; pediatric residency training from Children's Hospital, Boston; and fellowship training at Massachusetts General Hospital. He is board certified in Neurology with Special Competence in Child Neurology.
Dr. Kosofsky's research centers on the interaction of maternal, genetic, and postnatal influences on the development of the child brain. He has been particularly concerned with the impact of maternal substance abuse on fetal brain development and the implications on subsequent behavior. In his clinical practice, Dr. Kosofsky will continue his commitment to treat drug- and alcohol-exposed children.
Dr. Kosofsky currently serves as the Chair of the Scientific Selection Committee for the Child Neurology Society. He also founded and directed the Substances of Abuse Exposure Follow-up (SAEF) Clinic, which has recently expanded to include a clinical research component utilizing high-resolution structural brain imaging methods to better diagnose and treat diseases affecting the developing brain, including such prenatal toxic exposures.
Dr. Mark E. Dovey
Dr. Mark E. Dovey was appointed Assistant Professor of Pediatrics at Weill Cornell Medical College and Assistant Attending Pediatrician at NewYork-Presbyterian/Weill Cornell. He was previously Instructor in Pediatrics at Harvard Medical School and Assistant in Pulmonary Medicine at Children's Hospital, Boston. He received a medical degree from Duke University School of Medicine, pediatric residency training at Johns Hopkins Hospital, and pediatric pulmonary fellowship training at Boston Children's Hospital. He is board certified in both Pediatrics and Pediatric Pulmonology.
Dr. Dovey's research training and experience have focused on the clinical investigation of disease markers and novel therapeutic agents for cystic fibrosis lung disease.2453291pubjvb9001&&17:08-11- 4-2004kebloom10:30-10-13-200410_12c_043>Dr. Barry E. Kosofsky
Dr. Barry E. Kosofsky, who has also been named Professor of Pediatrics at Weill Cornell Medical College and Attending Pediatrician at NewYork-Presbyterian/Weill Cornell, joins the Hospital following 19 years at Harvard Medical School, where he was Associate Professor of Neurology. At Massachusetts General Hospital, he was Associate Neurologist and Director of the Child Neurology Residency Training Program. Dr. Kosofsky received a medical degree and Ph.D. from Johns Hopkins University; pediatric residency training from Children's Hospital, Boston; and fellowship training at Massachusetts General Hospital. He is board certified in Neurology with Special Competence in Child Neurology.
Dr. Kosofsky's research centers on the interaction of maternal, genetic, and postnatal influences on the development of the child brain. He has been particularly concerned with the impact of maternal substance abuse on fetal brain development and the implications on subsequent behavior. In his clinical practice, Dr. Kosofsky will continue his commitment to treat drug- and alcohol-exposed children.
Dr. Kosofsky currently serves as the Chair of the Scientific Selection Committee for the Child Neurology Society. He also founded and directed the Substances of Abuse Exposure Follow-up (SAEF) Clinic, which has recently expanded to include a clinical research component utilizing high-resolution structural brain imaging methods to better diagnose and treat diseases affecting the developing brain, including such prenatal toxic exposures.
Dr. Mark E. Dovey
Dr. Mark E. Dovey was appointed Assistant Professor of Pediatrics at Weill Cornell Medical College and Assistant Attending Pediatrician at NewYork-Presbyterian/Weill Cornell. He was previously Instructor in Pediatrics at Harvard Medical School and Assistant in Pulmonary Medicine at Children's Hospital, Boston. He received a medical degree from Duke University School of Medicine, pediatric residency training at Johns Hopkins Hospital, and pediatric pulmonary fellowship training at Boston Children's Hospital. He is board certified in both Pediatrics and Pediatric Pulmonology.
Dr. Dovey's research training and experience have focused on the clinical investigation of disease markers and novel therapeutic agents for cystic fibrosis lung disease.2453291pubjvb9001&&17:08-11- 4-2004kebloom10:30-10-13-200410_12c_04
